Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.599
-0.042 (-6.56%)
Nov 21, 2024, 2:14 PM EST - Market open
Lineage Cell Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$4.75
Upside
+692.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +233.72% | Nov 20, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +400.58% | Nov 18, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +567.45% | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | Mar 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | Feb 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +901.17% | Feb 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | Aug 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +901.17% | Jul 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | Jul 24, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | May 12, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,068.03% | Apr 26, 2023 |
| Baird | Baird | Buy Initiates $5 | Buy | Initiates | $5 | +734.31% | Nov 2, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +567.45% | Jun 14, 2022 |
| Noble Capital Markets | Noble Capital Markets | Buy Initiates $8 | Buy | Initiates | $8 | +1,234.89% | Aug 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $6 | Buy | Initiates | $6 | +901.17% | Mar 31, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.